Year archive

ISLAND PHARMACEUTICALS LIMITED — 2025 filings

All 116 regulatory filings released by ISLAND PHARMACEUTICALS LIMITED (ILA) in 2025, sourced directly from the official regulator.

116 Filings

2025 Period

2025 filings (116)

Filing	Released	Lang
Agreement with Texas Biomed for Galidesivir Program 3 pages 442.0KB Capital/Financing Update	2025-12-16	English
Change in substantial holding 2 pages 306.8KB Major Shareholding Notification	2025-12-08	English
Change in substantial holding 2 pages 1.3MB Regulatory Filings	2025-12-08	English
Change in substantial holding 2 pages 131.3KB Major Shareholding Notification	2025-12-08	English
Island expands Galidesivir IP with US Patent Grant 2 pages 137.4KB Regulatory Filings	2025-12-04	English
Additional FDA Submission completed for Galidesivir 2 pages 140.0KB Capital/Financing Update	2025-12-03	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2025-12-02	English
Cleansing Notice 1 page 137.7KB Capital/Financing Update	2025-12-02	English
Options exercised raises $1million 2 pages 116.6KB Capital/Financing Update	2025-12-02	English
Change of Director's Interest Notice - CN & JC 7 pages 329.4KB Director's Dealing	2025-12-02	English
Coalition acceptance to advance US procurement & stockpiling 3 pages 294.3KB Capital/Financing Update	2025-11-23	English
Island engages advisers to advance biodefence strategy 2 pages 141.5KB Regulatory Filings	2025-11-19	English
FDA agrees Animal Rule pathway and PRV eligibility 18 pages 1.7MB Capital/Financing Update	2025-11-16	English
Change of registered address 2 pages 154.0KB Regulatory Filings	2025-11-13	English
Notification regarding unquoted securities - ILA 8 pages 26.5KB Share Issue/Capital Change	2025-11-12	English
Change of Director's Interest Notice - DF, JC & CN 11 pages 368.5KB Director's Dealing	2025-11-12	English
Trading Halt 2 pages 255.3KB Regulatory Filings	2025-11-12	English
Webinar - FDA response to Galidesivir program 2 pages 143.4KB Regulatory Filings	2025-11-12	English
Change of Director's Interest Notice - DF 3 pages 179.7KB Director's Dealing	2025-11-04	English
Change of Director's Interest Notice - CN 3 pages 237.0KB Director's Dealing	2025-11-04	English
Quarterly Appendix 4C and Activities Report 11 pages 485.0KB Interim / Quarterly Report	2025-10-29	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2025-10-29	English
Cleansing Notice 1 page 141.3KB Regulatory Filings	2025-10-29	English
FDA confirms response timing for Galidesivir 2 pages 140.3KB Regulatory Filings	2025-10-21	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2025-10-16	English
Cleansing Notice 1 page 272.7KB Share Issue/Capital Change	2025-10-16	English
Results of AGM 3 pages 162.4KB Declaration of Voting Results & Voting Rights Announcements	2025-10-08	English
Notification regarding unquoted securities - ILA 6 pages 18.6KB Share Issue/Capital Change	2025-10-02	English
US FDA Type C meeting briefing document submitted 2 pages 139.5KB Regulatory Filings	2025-09-28	English
FDA Meeting request granted 2 pages 138.8KB Regulatory Filings	2025-09-18	English
Investor webinar 2 pages 134.9KB Regulatory Filings	2025-09-17	English
Investor presentation - Galidesivir update 23 pages 1.9MB Investor Presentation	2025-09-16	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2025-09-08	English
Cleansing Notice 1 page 202.0KB Share Issue/Capital Change	2025-09-08	English
Letter to Shareholders, Notice of AGM & Proxy Form 38 pages 709.6KB AGM Information	2025-09-04	English
FDA meeting request lodged for Galidesivir 2 pages 152.8KB Regulatory Filings	2025-08-31	English
Preliminary Final Report 2 pages 231.7KB Earnings Release	2025-08-28	English
Annual Report to shareholders 58 pages 3.1MB Regulatory Filings	2025-08-28	English
Appendix 4G and Corporate Governance Statement 28 pages 760.3KB Regulatory Filings	2025-08-28	English
Annual Report to shareholders (incl auditor independence) 58 pages 3.2MB Regulatory Filings	2025-08-28	English
Change in substantial holding 3 pages 129.8KB Major Shareholding Notification	2025-08-14	English
Presentation to the Third Annual Dengue Endgame Summit 25 pages 1.0MB Investor Presentation	2025-08-13	English
Date of AGM & Closing Date for Director Nominations 2 pages 276.9KB AGM Information	2025-08-13	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-08-10	English
Cleansing Notice 1 page 186.9KB Capital/Financing Update	2025-08-10	English
Options exercise from existing substantial shareholder 2 pages 144.7KB Capital/Financing Update	2025-08-10	English
Completion of Galidesivir transaction 2 pages 154.1KB Capital/Financing Update	2025-07-30	English
Investor Presentation and investor roadshow 39 pages 2.0MB Investor Presentation	2025-07-27	English
Change of Director's Interest Notice - JC 2 pages 5.3KB Director's Dealing	2025-07-24	English
Quarterly Appendix 4C and Activities Report 11 pages 429.2KB Interim / Quarterly Report	2025-07-23	English
Options exercise from existing substantial shareholder 2 pages 221.5KB Regulatory Filings	2025-07-16	English
Change in substantial holding 3 pages 941.0KB Director's Dealing	2025-07-16	English
Application for quotation of securities - ILA 7 pages 21.3KB Share Issue/Capital Change	2025-07-15	English
Cleansing Notice 1 page 136.7KB Capital/Financing Update	2025-07-15	English
Portfolio expansion achieved with acquisition of Galidesivir 6 pages 205.1KB Capital/Financing Update	2025-07-08	English
Investor presentation 18 pages 1.0MB Investor Presentation	2025-07-08	English
Trading Halt 2 pages 344.9KB Regulatory Filings	2025-07-06	English
Cancel - Notification of cessation of securities - ILA 4 pages 14.6KB Regulatory Filings	2025-07-03	English
Notification of cessation of securities - ILA 4 pages 15.0KB Regulatory Filings	2025-07-03	English
Final Director's Interest Notice 2 pages 290.7KB Director's Dealing	2025-07-02	English
Notification of cessation of securities - ILA 4 pages 14.9KB Share Issue/Capital Change	2025-07-02	English
Initial Director's Interest Notice 2 pages 269.2KB Director's Dealing	2025-07-02	English
Appointment of Jason Carroll as Non-Executive Chairman 2 pages 150.8KB Board/Management Information	2025-07-01	English
Webinar presentation 26 pages 1.7MB Investor Presentation	2025-06-16	English
Successful Phase 2 clinical trial of ISLA-101 6 pages 213.1KB Capital/Financing Update	2025-06-11	English
Trading Halt 2 pages 334.2KB Regulatory Filings	2025-06-09	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2025-06-03	English
Cleansing Notice 1 page 196.2KB Capital/Financing Update	2025-06-03	English
Change in substantial holding 3 pages 954.9KB Major Shareholding Notification	2025-06-02	English
Change in substantial holding 3 pages 278.0KB Major Shareholding Notification	2025-06-01	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2025-05-28	English
Cleansing Notice 1 page 137.9KB Capital/Financing Update	2025-05-28	English
Change in substantial holding 2 pages 301.3KB Major Shareholding Notification	2025-05-28	English
Island completes $3.6 million placement 3 pages 170.2KB Capital/Financing Update	2025-05-20	English
Proposed issue of securities - ILA 5 pages 18.0KB Capital/Financing Update	2025-05-20	English
Proposed issue of securities - ILA 5 pages 18.1KB Capital/Financing Update	2025-05-20	English
Proposed issue of securities - ILA 5 pages 17.2KB Share Issue/Capital Change	2025-05-20	English
Trading Halt 2 pages 359.8KB Capital/Financing Update	2025-05-18	English
Investor Presentation 22 pages 1.8MB Investor Presentation	2025-05-07	English
Quarterly Activities & Cashflow Report 11 pages 389.0KB Interim / Quarterly Report	2025-04-29	English
Phase 2a/b clinical trial update 3 pages 163.4KB Regulatory Filings	2025-04-22	English
Notification of cessation of securities - ILA 4 pages 14.8KB Share Issue/Capital Change	2025-04-13	English
Change in substantial holding 3 pages 159.3KB Major Shareholding Notification	2025-03-25	English
Change in substantial holding 3 pages 272.9KB Major Shareholding Notification	2025-03-24	English
Ceasing to be a substantial holder 2 pages 126.1KB Major Shareholding Notification	2025-03-24	English
Spark Plus Healthcare Conference Investor Presentation 19 pages 1.7MB Investor Presentation	2025-03-23	English
Change in substantial holding 2 pages 303.4KB Major Shareholding Notification	2025-03-23	English
Change in substantial holding 3 pages 919.6KB Major Shareholding Notification	2025-03-20	English
Application for quotation of securities - ILA 21 pages 492.9KB Regulatory Filings	2025-03-18	English
Change of Director's Interest Notice - PL 3 pages 167.9KB Director's Dealing	2025-03-18	English
Notification of cessation of securities - ILA 4 pages 259.5KB Regulatory Filings	2025-03-18	English
Total of $2.72m raised from ILAO options 3 pages 166.4KB Capital/Financing Update	2025-03-18	English
Application for quotation of securities - ILA 21 pages 492.8KB Regulatory Filings	2025-03-11	English
Application for quotation of securities - ILA 6 pages 19.2KB Share Issue/Capital Change	2025-03-04	English
Application for quotation of securities - ILA 6 pages 19.2KB Share Issue/Capital Change	2025-03-04	English
Cleansing Notice 1 page 139.5KB Capital/Financing Update	2025-03-04	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-03-04	English
Change of Director's Interest Notice - DF 3 pages 179.0KB Director's Dealing	2025-03-04	English
Appendix 4D & Half-Year Financial Statements 20 pages 1.1MB Interim / Quarterly Report	2025-02-26	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-02-25	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-02-18	English
Change in substantial holding 3 pages 305.2KB Major Shareholding Notification	2025-02-18	English
Change of Director's Interest Notice (PL) 3 pages 223.2KB Director's Dealing	2025-02-12	English
Notification regarding unquoted securities - ILA 6 pages 19.5KB Share Issue/Capital Change	2025-02-12	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-02-11	English
Completion of patient dosing in Phase 2b clinical trial 3 pages 456.5KB Regulatory Filings	2025-02-11	English
ILAO option expiry reminder and exercise instructions 2 pages 146.6KB Capital/Financing Update	2025-02-05	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-02-04	English
Final Director's Interest Notice - AH 2 pages 271.0KB Director's Dealing	2025-02-02	English
Quarterly Activities & Cashflow Report 11 pages 418.9KB Interim / Quarterly Report	2025-01-29	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-01-28	English
Results of EGM 1 page 24.0KB Declaration of Voting Results & Voting Rights Announcements	2025-01-27	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-01-21	English
Completion of enrolment in Phase 2b arm 2 pages 149.5KB Capital/Financing Update	2025-01-21	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2025-01-14	English
ISLA-101 Phase 2b clinical trial enrols first subjects 2 pages 618.0KB Capital/Financing Update	2025-01-07	English